GIC Discloses Third Change in Shareholding in Ascletis Pharma Inc. -B (01672.HK) This Year: Further Increases Stake by Over 10 Million Shares, Raising Holding from 7.00% to 8.36%
HONG KONG, Jun 26, 2026 – (ACN Newswire via SeaPRwire.com) – Recently, Singapore’s sovereign wealth fund GIC updated its shareholding data for Ascletis Pharma Inc. -B (01672.HK) once again, marking its third Disclosure of Interests filing in the company this year.
More